Scienture stock surged 355% on the commercial launch of Arbli, the first FDA-approved liquid losartan, backed by extensive distribution deals.

Palworld reveals what players can expect in the game's Halloween 2025 update, which includes a new mission and rewards for ...

Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli™ as the ...